Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Wang

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Neuro-Oncology|July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cellsPhilipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
Nature Communications|November 26, 2021
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Cancer Cell|April 24, 2018
A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor MicroenvironmentAmelie Griveau, Giorgio Seano, Samuel J Shelton, et al.
Nature Communications|October 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Nature Communications|October 13, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosisPriscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Neuro-Oncology|October 6, 2025
Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology CollaborativeAkanksha Sharma, Lucy Boyce Kennedy, Amanda E D Van Swearingen, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
Nature Genetics|April 1, 2022
Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individualsAysu Okbay, Yeda Wu, Nancy Wang, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Neuro-Oncology|July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cellsPhilipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
Nature Communications|November 26, 2021
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Cancer Cell|April 24, 2018
A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor MicroenvironmentAmelie Griveau, Giorgio Seano, Samuel J Shelton, et al.
Nature Communications|October 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Nature Communications|October 13, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosisPriscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Neuro-Oncology|October 6, 2025
Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology CollaborativeAkanksha Sharma, Lucy Boyce Kennedy, Amanda E D Van Swearingen, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
Nature Genetics|April 1, 2022
Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individualsAysu Okbay, Yeda Wu, Nancy Wang, et al.
Pageof 18